Neogenomics Inc logo

NEO - Neogenomics Inc News Story

$32.34 -0.4  -1.3%

Last Trade - 02/12/21

Large Cap
Market Cap £3.04bn
Enterprise Value £3.03bn
Revenue £365.0m
Position in Universe 1620th / 7292

BUZZ-Biden's planned tax hike to have modest impact on healthcare cos - Needham

Fri 9th April, 2021 12:08pm
** Brokerage Needham says Biden administration's proposed
increase in U.S. corporate tax rate to have biggest impact on
diagnostics co NeoGenomics  NEO.O  and affect medtech co Conmed
Corp  CNMD.O  the least  
    ** Analysts at Needham performed a sensitivity analysis to
gauge impact on cos in coverage universe
    ** All else being equal, an increase in the tax rate to 25%
would reduce EPS at these companies by an average of 3.2% -
    ** For every 100 bps increase in U.S. corporate tax rate,
analysts estimate NEO to see greatest headwind to 2022E adjusted
EPS, followed by Globus Medical  GMED.N , Cantel Medical
 CMD.N , NuVasive  NUVA.O  and Hologic  HOLX.O   
    ** Conmed, Medtronic  MDT.N , LivaNova  LIVN.O , Hillrom
 HRC.N  and Boston Scientific  BSX.N   would see smallest impact
to 2022E adjusted EPS - Needham
    ** Brokerage expects only some profitable companies to be
negatively impacted from a stock perspective    
    ** Biden administration is working on an infrastructure
package that is expected to include an increase in the corporate
tax rate to an estimated 25% to help fund spending*:nL1N2LZ1LP 

 (Reporting by Vishwadha Chander in Bengaluru)
 ((; within U.S. +1 646 223
8780, outside U.S. +91 80 6749 6132;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.